Citation Impact
Citing Papers
Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma
2017
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts
2019
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication
2018 StandoutNobel
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
2013
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
La greffe de tissu adipeux : mythe ou réalité scientifique. Lecture critique de la littérature
2005
Evaluation of Cladribine treatment in refractory celiac disease type II
2011
Seasonal variations in pineal 5‐methoxytryptophol (5‐ML) concentrations and in the daily pattern of pineal 5‐ML and melatonin in the desert rodent Jaculus orientalis: Effect of prolonged illumination during the night
1992
5-Methoxytryptophol injections in the Syrian hamster: Plasma and pineal concentrations
1990
Neural Adrenergic/Cyclic AMP Regulation of the Immunoglobulin E Receptor α-Subunit Expression in the Mammalian Pinealocyte
2007
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
The Blood–Brain Barrier
2015 Standout
The use of machine learning for the identification of peripheral artery disease and future mortality risk
2016
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
2009 Standout
Melatonin biosynthesis in the mammalian pineal gland
1989
The Levels of Evidence and Their Role in Evidence-Based Medicine
2011 Standout
Autophagy in mammalian development and differentiation
2010 Standout
The significance of the metabolism of the neurohormone melatonin: Antioxidative protection and formation of bioactive substances
1993 Standout
Interferon therapy in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis of the comparative trials
2010
Nomograms in oncology: more than meets the eye
2015 Standout
Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age
2007
Emerging oral therapies for multiple sclerosis
2007
New light is shining on the melatonin rhythm enzyme
1996
GASTROINTESTINAL MANIFESTATIONS OF SCLERODERMA
1998
IgE and mast cells in allergic disease
2012 Standout
Systemic sclerosis
2017 Standout
The Immunomodulatory Drug Glatiramer Acetate is Also an Effective Antimicrobial Agent that Kills Gram-negative Bacteria
2017
The immune contexture in cancer prognosis and treatment
2017 Standout
Pediatric Multiple Sclerosis
2011
A Critical Look at the Evidence for and against Elective Epinephrine Use in the Finger
2006
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Fecal Incontinence in Systemic Sclerosis Is Secondary to Neuropathy
2011
Developmental expression of LC3α and β: Absence of fibronectin or autophagy phenotype in LC3β knockout mice
2007
Apop-1, a Novel Protein Inducing Cyclophilin D-dependent but Bax/Bak-related Channel-independent Apoptosis
2006 StandoutNobel
Sexual dysfunction and infertility as late effects of cancer treatment
2014
Immunopathology of multiple sclerosis
2015 Standout
Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre
2010
Acute kidney injury
2021 Standout
A survey on deep learning in medical image analysis
2017 Standout
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
2010 Standout
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Chronic kidney disease
2017
Methods in Mammalian Autophagy Research
2010 Standout
An Analysis of Radical Prostatectomy in Advanced Stage and High-Grade Prostate Cancer
2007
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Behavioral and neurochemical characterization of α2A-adrenergic receptor knockout mice
2002 StandoutNobel
How do immune cells overcome the blood–brain barrier in multiple sclerosis?
2011
Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*
1991 Standout
ESPEN Guidelines on Enteral Nutrition: Gastroenterology
2006
Diurnal variation in norepinephrine-stimulated release of pineal serotonin in vitro
1989
Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice to evaluate potential for soft tissue engineering
2005
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
2019 Standout
On the mechanisms of biocompatibility
2008 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Do Not Use Epinephrine in Digital Blocks: Myth or Truth? Part II. A Retrospective Review of 1111 Cases
2010
Therapies for multiple sclerosis: translational achievements and outstanding needs
2013
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Renal cell carcinoma
2017 Standout
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
2011
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
2013
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Structural Fat Grafting: More Than a Permanent Filler
2006 Standout
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
2018 Standout
A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects
2014
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Role of apoptosis in atherosclerosis and its therapeutic implications
2004
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis
2013
Apoptosis During Cardiovascular Development
2000
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Enzyme replacement therapy for Anderson-Fabry disease
2016
American Cancer Society prostate cancer survivorship care guidelines
2014
Deep 3D Convolutional Encoder Networks With Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation
2016
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
1995 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity
2015
Multiple Sclerosis
2018 Standout
Melatonin: A Coordinating Signal for Mammalian Reproduction?
1985 Science
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
2015
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b
2007
Cancer treatment and survivorship statistics, 2016
2016 Standout
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
2019 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Human Infection withFusobacterium necrophorum(Necrobacillosis), with a Focus on Lemierre's Syndrome
2007
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
2004 Standout
Arylamine N-acetyltransferase and arylalkylamine N-acetyltransferase in the mammalian pineal gland.
1984
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Gastrointestinal manifestations of systemic sclerosis
2016
Pineal indoles: Significance and measurement
1986
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
2011
Long-Term Outcome Of Autologous Fat Transplantation In Aesthetic Facial Recontouring
2000
Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America
2012 Standout
Deep Learning in Medical Image Analysis
2017 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Flow-Induced Vascular Remodeling in the Mouse
2003
Works of Peter Chang being referenced
Agalsidase alfa in pediatric patients with Fabry disease: a 6.5-year open-label follow-up study
2014
Measuring and Predicting Prostate Cancer Related Quality of Life Changes Using EPIC for Clinical Practice
2013
Benefits of high-dose, high-frequency interferon beta-1a in relapsing–remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trial
2005
Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study
2008
Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease
2015
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
2010
Index of Suspicion
2006
Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry
2015
Growth Hormone, Glutamine, and an Optimal Diet Reduces Parenteral Nutrition in Patients With Short Bowel Syndrome
2005
Living Donor Age and Kidney Allograft Half-Life
2012
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
2008
The long‐term safety and tolerability of high‐dose interferon β‐1a in relapsing–remitting multiple sclerosis: 4‐year data from the PRISMS study
2005
A Multicenter Prospective Study of 3,110 Consecutive Cases of Elective Epinephrine Use in the Fingers and Hand: The Dalhousie Project Clinical Phase
2005
Effect of Physical Activity Assessment on Prognostication for Peripheral Artery Disease and Mortality
2015
Lipo Layering of Autologous Fat: An Improved Technique with Promising Results
1998
Fecal Incontinence in Scleroderma
1997
Improved Reclassification of Mortality Risk by Assessment of Physical Activity in Patients Referred for Exercise Testing
2014
An open-label clinical trial of agalsidase alfa enzyme replacement therapy in children with Fabry disease who are naïve to enzyme replacement therapy
2016
Long-Term Survival in Men With High Grade Prostate Cancer: A Comparison Between Conservative Treatment, Radiation Therapy and Radical Prostatectomy—A Propensity Scoring Approach
2007
A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif®) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis
2005
Reciprocal Day/Night Relationship between Serotonin Oxidation and N-Acetylation Products in the Rat Pineal Gland*
1983
Expanded Prostate Cancer Index Composite for Clinical Practice: Development and Validation of a Practical Health Related Quality of Life Instrument for Use in the Routine Clinical Care of Patients With Prostate Cancer
2011
Clinical and socioeconomic factors associated with unrecognized peripheral artery disease
2014
The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis
2005
Nitric oxide mediates LC‐3‐dependent regulation of fibronectin in ductus arteriosus intimal cushion formation
1999